Donate

The Changing Role of PARP Inhibitors in the Treatment of Ovarian Cancer

The Changing Role cover

In recent years, researchers have been looking into using a class of drugs called PARP inhibitors to prevent the progression and recurrence of ovarian cancer. Dr. Kathleen Moore of Stephenson Cancer Center, Principal Investigator of the SOLO-1 trial, explains how the results of this trial may affect ovarian cancer patients and where research on ovarian […]

Understanding and Treating HER2+ Breast Cancer

Understanding and Treating HER2 Breast Cancer 01

Dr. Rena Callahan, a hematologist-oncologist of the Ronald Reagan UCLA Medical Center and Assistant Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA, discusses HER2+ breast cancer, its current treatment, and possible treatment advances. This webinar took place on December 3, 2018. https://www.youtube.com/watch?v=QyX0CTFQsK4

Understanding Genetic Counseling

Ovarian Cancer Maintenance Therapies Copy New York SHARE Cancer Support 1

Rania Sheikh, MS, a certified genetic counselor from Memorial Sloan Kettering Cancer Center, provides an overview of the role of a genetic counselor in cancer diagnosing and treatment. Further, she explains how women can access counselors and how genetics can impact treatment options. https://www.youtube.com/watch?v=ec2Sf9zYUuU

Immunotherapy in the Management of Ovarian Cancer

immunotherapyimage

Wish you could talk to the expert behind the video? Enter your email to join our program reminder list, so you can be the first to know about new webinars, join them live, and ask the presenter questions. In this webinar, held on May 17, 2017, Dr. Maurie Markman, President of Science and Medicine at […]

Donate